Andreas Mayr

VN-EGNN improves drug development by enhancing binding site identification on proteins.

This study presents an efficient method for balancing updates in GAMLSS using adaptive step lengths.

Bio-xLSTM uses advanced models to analyze complex biological sequences for better science.